Literature DB >> 6366142

Human tumor cell heterogeneity and metastasis.

E N Spremulli, D L Dexter.   

Abstract

Heterogeneity within malignant neoplasms, although described for many years by pathologists, has only recently been extensively studied in the laboratory. It is now accepted that most tumors are composed of subpopulations of cells that differ in many phenotypic characteristics including the ability to form a metastasis. Cells with the capacity to metastasize are the ones most likely to prove lethal to the patient since clinicians can often control the primary neoplasm with surgery or radiotherapy. In this report the process of metastasis is discussed, those aspects of tumor cell heterogeneity that are relevant to this process are reviewed, intrapatient tumor heterogeneity is explored, and future preclinical studies are evaluated that may be useful in designing treatment strategies for patients with disseminated malignancies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6366142     DOI: 10.1200/JCO.1983.1.8.496

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  19 in total

1.  Discriminate gene lists derived from cDNA microarray profiles of limited samples permit distinguishing mesenchymal neoplasia ex vivo.

Authors:  David E Joyner; Mark L Wade; Aniko Szabo; Jeffrey Bastar; Cheryl M Coffin; Karen H Albritton; Philip S Bernard; R Lor Randall
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-22       Impact factor: 4.553

2.  Mathematical modeling of cancer cell invasion of tissue: biological insight from mathematical analysis and computational simulation.

Authors:  Vivi Andasari; Alf Gerisch; Georgios Lolas; Andrew P South; Mark A J Chaplain
Journal:  J Math Biol       Date:  2010-09-26       Impact factor: 2.259

Review 3.  To differentiate or not--routes towards metastasis.

Authors:  Thomas Brabletz
Journal:  Nat Rev Cancer       Date:  2012-05-11       Impact factor: 60.716

4.  Expression of Fas ligand in liver metastases of human colonic adenocarcinomas.

Authors:  K Shiraki; N Tsuji; T Shioda; K J Isselbacher; H Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 5.  Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.

Authors:  Deepika Neelakantan; David J Drasin; Heide L Ford
Journal:  Cell Adh Migr       Date:  2014-10-16       Impact factor: 3.405

Review 6.  Chemotherapeutic drug resistance in the management of head and neck cancer.

Authors:  H Bier
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

7.  Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase.

Authors:  N Mitsiades; V Poulaki; V Kotoula; A Leone; M Tsokos
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

8.  Is the testis a chemo-privileged site? Is there a blood-testis barrier?

Authors:  Dhiren S Dave; John T Leppert; Jacob Rajfer
Journal:  Rev Urol       Date:  2007

9.  Detection of metastasis-associated differences for receptors of glycoconjugates (lectins) in histomorphologically unchanged xenotransplants from primary and metastatic lesions of human colon adenocarcinomas.

Authors:  H J Gabius; T Ciesiolka; E Kunze; K Vehmeyer
Journal:  Clin Exp Metastasis       Date:  1989 Sep-Oct       Impact factor: 5.150

10.  Thermo-Sensitive Liposome co-Loaded of Vincristine and Doxorubicin Based on Their Similar Physicochemical Properties had Synergism on Tumor Treatment.

Authors:  Mingyuan Li; Zhiping Li; Yang Yang; Zhiyuan Wang; Zhenbo Yang; Bingsheng Li; Xiangyang Xie; Jinwen Song; Hui Zhang; Ying Li; Guangyu Gao; Jingyuan Yang; Xingguo Mei; Wei Gong
Journal:  Pharm Res       Date:  2016-04-13       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.